When he was 3 years old and falling behind in his childhood development, doctors diagnosed Jonathan Oliphint with a rare genetic disease. There was a known treatment for the disease, in which the body produces an excess amount of ammonia, and doctors at Texas Children’s Hospital soon began giving the boy a critical amino acid, arginine, his body was not making
Public release date: 25-Apr-2012 [ | E-mail | Share ] Contact: Bryan Alary bryan.alary@ualberta.ca 780-492-0436 University of Alberta (Edmonton) You wouldn’t know it from appearances, but a metal cube the size of a toaster, created at the University of Alberta, is capable of performing the same genetic tests as most fully equipped modern laboratoriesand in a fraction of the time.
SAN DIEGO–(BUSINESS WIRE)– Pathway Genomics Corporation, a genetic testing laboratory specializing in nutrition and exercise response, inherited disease, prescription drug response and health condition risks, has established a world-leading scientific advisory board. Among the board members are James Fowler, Ph.D., professor of medical genetics at UCSD School of Medicine, Christoph Lange, Ph.D., associate professor of biostatistics at Harvard University School of Public Health, and Nicholas Schork, Ph.D., director of bioinformatics and biostatistics at the Scripps Translational Science Institute.
Published on April 25, 2012 at 1:52 AM Thomas R. Terrell, MD presented “Prospective Cohort Study of the Association of Genetic Polymorphisms and Concussion Risk and Postconcussion Neurocognitive Deficits in College Athletes” at the 21st American Medical Society for Sports Medicine Annual Meeting in Atlanta, Ga
Newswise ATLANTA, Ga. Thomas R.
DETROIT, April 20, 2012 /PRNewswire-USNewswire/ — A Wayne State University School of Medicine researcher is one step closer to understanding the genetic basis that enable bonobos, one of humankind's sibling species, to learn language, play music and use rudimentary tools.
Fluidigm has tapped Dan Clutter as North American sales director for its eastern sales region.
Researchers have created artificial genetic material known as Xenonucleic acids, or XNAs, that can store information and evolve over generations in a comparable way to DNA. The research, reported Friday in the journal Science, has implications for the fields of molecular medicine and biotechnology, and sheds new light on how molecules first replicated and assembled into life billions of years ago.
Via Scoop.it – inPharmaticsBiopharmaceutical vendor AstraZeneca has launched a unified communications pilot using Microsoft Lync to improve collaboration among pharmaceutical sales reps, doctors and researchers.Via mobile.eweek.com Source:http://microarray.wordpress.com/feed/
Public release date: 9-Apr-2012 [ | E-mail | Share ] Contact: Lauren Woods law2014@med.cornell.edu 212-821-0560 New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College NEW YORK (April 9, 2012 ) — An international research team led by Weill Cornell Medical College investigators have discovered two inherited-genetic deletions in the human genome linked to development of aggressive prostate cancer. The findings, published online today in the Proceedings of the National Academy of Sciences (PNAS), indicate a man’s risk of developing prostate cancer either triples or quadruples, depending on the genetic variant they inherit. In the study, one genetic deletion is shown to affect the functioning of a known gene, while the other, found in a non-coding area of the genome once considered to be “junk DNA,” seems to be regulating a cascade of genes
A supporter of Republican presidential hopeful and former U.S.
DUBAI New genetic tests that can indicate complications in the embryo such as thalassemia and Down Syndrome as early as 11-14 weeks into pregnancy has enabled parents in the UAE to make an informed choice.
ScienceDaily (Apr. 10, 2012) Nearly 18 percent of U.S
DUBAI New genetic tests that can indicate complications in the embryo such as thalassemia and Down Syndrome as early as 11-14 weeks into pregnancy has enabled parents in the UAE to make an informed choice. Mothers-to-be have been urged to consider detailed pre-natal genetic screening and testing to rule out abnormalities in their unborn child as well as identify any potential future health risks. Thalassemia, a chronic blood disorder, is one of the most common genetic complications affecting the local population.
Public release date: 9-Apr-2012 [ | E-mail | Share ] Contact: Jessica Studeny jessica.studeny@case.edu 216-368-4692 Case Western Reserve University While exercise is accepted universally as the most beneficial prescription physicians can write for patients, little is known about the molecular mechanisms that generate its widespread health benefits. Researchers from Case Western Reserve School of Medicine have shed light on this mystery by discovering that a genetic factor, Kruppel-like Factor 15 (KLF15), governs the body’s ability to burn fat during exercise. Previous research from the laboratory of Mukesh Jain, MD, FAHA, identified the importance of KLF15 in the metabolism of two of the three basic nutrients used by the human body: sugar and protein
Via Scoop.it – inPharmatics Quintiles and the American Diabetes Association announced a strategic agreement in which Quintiles’ Digital Patient Unit will provide the Association’s millions of website users access to Quintiles’ medication monitoring service. The Association’s constituents who opt in for the service will receive free safety checks of their medications to identify potential [...]
Public release date: 1-Apr-2012 [ | E-mail | Share ] Contact: Caroline Arbanas arbanasc@wustl.edu 314-286-0109 Washington University School of Medicine Scientists at Washington University School of Medicine in St. Louis are using powerful DNA sequencing technology not only to identify mutations at the root of a patient’s tumor considered key to personalizing cancer treatment but to map the genetic evolution of disease and monitor response to treatment. “We’re finding clinically relevant information in the tumor samples we’re sequencing for discovery-oriented research studies,” says Elaine Mardis, PhD, co-director of The Genome Institute at the School of Medicine
Published on April 2, 2012 at 3:01 AM University of North Carolina at Chapel Hill researchers working as part of the International Cystic Fibrosis Consortium have discovered several regions of the genome that may predispose cystic fibrosis (CF) patients to develop an intestinal blockage while still in the uterus. A report of this international study appears online April 1, 2012 in the journal Nature Genetics. It was the work of the North America CF Gene Modifier Consortium, which brought together dozens of investigators from the United States, Canada, and from France, to identify genetic variations that could be linked with meconium ileus (MI), an intestinal obstruction that usually requires emergency surgery for treatment, and can result in a substantially increased rate of serious health problems.
Via Scoop.it – inPharmatics On March 29, 2012, Oracle announced that it has agreed to acquire ClearTrial, a leading provider of cloud-based Clinical Trial Operations and analytics products that make the planning, sourcing, and tracking of clinical projects and financial performance… Via www.oracle.com Source:http://microarray.wordpress.com/feed/
30-03-2012 11:44 Personalized medicine is becoming an increasingly important aspect of cancer treatment.